WNT signaling is involved in maintaining stem cells in an undifferentiated state; however, it is often unclear which WNTs and WNT receptors are mediating these activities. Here we examined the role of the WNT receptor FZD7 in maintaining human embryonic stem cells (hESCs) in an undifferentiated and pluripotent state. FZD7 expression is significantly elevated in undifferentiated cells relative to differentiated cell populations, and interfering with its expression or function, either by short hairpin RNA-mediated knockdown or with a fragment antigen binding (Fab) molecule directed against FZD7, disrupts the pluripotent state of hESCs. The FZD7-specific Fab blocks signaling by Wnt3a protein by downregulating FZD7 protein levels, suggesting that FZD7 transduces Wnt signals to activate Wnt/β-catenin signaling. These results demonstrate that FZD7 encodes a regulator of the pluripotent state and that hESCs require endogenous WNT/β-catenin signaling through FZD7 to maintain an undifferentiated phenotype.
WNT signaling is involved in maintaining stem cells in an undifferentiated state; however, it is often unclear which WNTs and WNT receptors are mediating these activities. Here we examined the role of the WNT receptor FZD7 in maintaining human embryonic stem cells (hESCs) in an undifferentiated and pluripotent state. FZD7 expression is significantly elevated in undifferentiated cells relative to differentiated cell populations, and interfering with its expression or function, either by short hairpin RNA-mediated knockdown or with a fragment antigen binding (Fab) molecule directed against FZD7, disrupts the pluripotent state of hESCs. The FZD7-specific Fab blocks signaling by Wnt3a protein by downregulating FZD7 protein levels, suggesting that FZD7 transduces Wnt signals to activate Wnt/β-catenin signaling. These results demonstrate that FZD7 encodes a regulator of the pluripotent state and that hESCs require endogenous WNT/β-catenin signaling through FZD7 to maintain an undifferentiated phenotype.
human pluripotent stem cell | self-renewal | differentiation C ontrol of stem cell self-renewal is critical to the development of multicellular life; however, our understanding of the molecular machinery regulating this process remains superficial. Several studies have demonstrated that the WNT/β-catenin signaling pathway is a critical regulator of stem cell self-renewal, and the hypothesis that WNT primarily acts to maintain stem cells in an undifferentiated state has garnered significant support (reviewed in refs. [1] [2] [3] [4] . This paradigm is especially apparent in various adult stem cell populations, such as in skin, intestine, and blood, where WNT/β-catenin signaling is essential for proper tissue homeostasis.
The role of WNT signaling in embryonic stem cells has been more controversial. In mouse embryonic stem cells, WNT/β-catenin signaling is active, and its inhibition shifts cells into an epiblast-like state (5) (6) (7) (8) (9) . In contrast, in human embryonic stem cells (hESCs), which more closely resemble mouse epiblast stem cells than mouse embryonic stem cells (10, 11) , WNT/β-catenin signaling is largely inactive, and ectopic stimulation of the pathway shifts them toward mesendodermal fates (12) (13) (14) .
Confounding the analysis of the role of WNT signaling in pluripotent stem cells is the large number of WNT ligands (the mammalian genome contains 19 Wnt genes) and WNT receptors encoded by the FZD gene family (the mammalian genome contains 10 Fzd genes), some of which may be acting redundantly. Furthermore, relatively little is known about the specificities of individual WNTs for individual receptors. Here we describe a set of experiments that demonstrate the presence of an endogenous WNT-FZD signaling loop that mediates a self-renewal signal in hESCs.
Results
Previous studies showed that Fzd7 is expressed in the epiblast of the developing mouse embryo (15) and that the human homolog FZD7 is elevated in undifferentiated human embryonic stem cells (hESCs) (16, 17) . We extended these studies by determining relative expression levels of all 10 FZD genes in hESCs using a whole-transcriptome sequencing (RNA-seq) data set. This analysis demonstrated that FZD7 is the most abundantly expressed FZD gene in the hESC line H1/WA01 (Fig. 1A) . Levels of the second and third most highly expressed FZD genes, FZD5 and FZD3, were 4.2-fold and 8.8-fold lower, respectively. That FZD7 is the most abundantly expressed FZD gene was confirmed using quantitative reverse transcription PCR (qRT-PCR) in a separate hESC line, HUES9 (Fig. S1A ). On differentiating hESCs to fibroblasts by withdrawal of the self-renewal signal fibroblast growth factor 2 (FGF2), expression levels of FZD7 declined significantly (Fig. 1B) . Similarly, on reprogramming of fibroblasts to an induced pluripotent state, FZD7 expression was increased (Fig. S1B ). Using previously published protocols (18), we differentiated hESCs (HUES9) into each of the three germ layers and monitored expression of all 10 FZD genes in each cell population relative to undifferentiated hESCs ( Fig. 1C and Fig. S1C ). We found that FZD7 expression was down-regulated in all differentiated cell populations relative to undifferentiated cells (Fig. 1C) . Differentiation into each lineage was monitored by expression of lineagespecific genes: SOX1 for ectoderm, T (brachyury) for mesoderm, and SOX17 for endoderm (Fig. 1C) . Given the consistent correlation of FZD7 gene expression with the pluripotent state, we performed additional experiments to address FZD7's functional importance in pluripotent stem cells.
Significance
Embryonic stem cells (ESCs) are unique in their ability to expand and self-renew indefinitely while retaining the potential to give rise to all mature cell types. The molecular mechanisms underlying these properties remain poorly understood. We investigated the role of the highly conserved WNT signaling pathway in controlling self-renewal and found that the WNT receptor encoded by the frizzled family receptor 7 (FZD7) gene is essential for maintaining human ESCs in an undifferentiated and pluripotent state. Using an FZD7-specific fragment antigen binding protein, as well as knockdown of FZD7 expression, we showed that the FZD7 receptor transduces a WNT/β-catenin signal in human ESCs. These data demonstrate that an endogenous WNT signaling loop is essential for the maintenance of human ESCs in an undifferentiated state.
To further characterize the role of FZD7 in hESCs, we tested a FZD7-specific fragment antigen binding (Fab) protein for its ability to bind FZD7, from here on referred to as FZD7-Fab. This Fab reacted with FZD7 overexpressed in HEK293 cells by immunoblotting ( Fig. 2A) . Other members of the FZD protein family, including the two most similar FZDs, FZD1 (79% identical to FZD7) and FZD2 (80% identical to FZD7), were not recognized by FZD7-Fab ( Fig. 2A) . By flow cytometry, FZD7-Fab effectively bound the cell surface of live HEK293 cells transiently transfected with a FZD7 expression vector (Fig. 2B ). FZD7-Fab also specifically recognized a protein in hESCs (HUES9) of similar molecular mass, as observed in HEK293 cells transfected with a FZD7 expression vector (Fig. 2C) , demonstrating that this Fab detects endogenously expressed FZD7 protein. Staining of live hESCs with FZD7-Fab followed by flow cytometry indicated that a large percentage of cells displayed this receptor on the cell surface ( Fig. 2D and Fig. S2 ). Fluorescence-based cell sorting to obtain cell populations with either high or low cell surface staining of FZD7 (FZD7 hi or FZD7 lo ), followed by qRT-PCR, demonstrated that FZD7-Fab can be used to enrich cells with higher levels of FZD7 expression (Fig. 2E) . Furthermore, the FZD7 hi population expressed significantly higher levels of the pluripotency markers NANOG (Fig. 2E) . Therefore, FZD7 marks hESCs with higher levels of expression of pluripotencyassociated genes, such as NANOG.
To explore the functional importance of FZD7 in undifferentiated hESCs, we took two approaches to disrupt its function: delivery of short hairpin RNA (shRNA) to knock down its ) and low levels (FZD7 Lo ) of FZD7 on the cell surface. qRT-PCR analysis revealed that expression of the pluripotency marker NANOG and FZD7 itself was significantly enriched in the FZD7
Hi population (mean ± SD of three technical samples, normalized to 18S and relative to FZD7 low populations). **P < 0.01. expression (Fig. 3) and application of FZD7-Fab to block its function (Fig. 4) . shRNAs were delivered using lentiviral transduction, and knockdown efficiency was determined for five independent shRNAs (Fig. S3A) . In support of our finding that hESCs with the highest FZD7 expression retain the highest levels of pluripotency marker expression (Fig. 2E ), we observed a direct correlation between the extent of FZD7 knockdown and reduction in expression of NANOG and POU5F1/OCT4 (Fig.  S3A) . Knockdown of FZD7 was accompanied by a loss in characteristic hESC morphology (colonies with sharp boundaries) and acquisition of a fibroblast-like morphology (Fig. 3A and Fig.  S3D ), as well as a significant reduction in expression of the pluripotency regulators NANOG and POU5F1/OCT4 in HUES9 cells (Fig. 3B ) and HUES6 cells (Fig. S3 B and C) . Therefore, disrupting FZD7 expression impairs the pluripotent state of hESCs.
Because FZD7-Fab specifically bound FZD7 protein on the surface of hESCs, we reasoned that it could potentially antagonize FZD7 function. To address this possibility, we examined the effect of prolonged treatment of hESCs with FZD7-Fab. Cells treated with FZD7-Fab showed a significant reduction in expression of the pluripotency markers OCT4/POU5F1 and NANOG ( Fig. 4A and Fig. S4A ), indicating that blocking FZD7 function impairs growth of hESCs in an undifferentiated state. This treatment, similar to the knockdown of FZD7 with shRNA, led to a reduction in expression of the FZD7 gene itself, an observation consistent with the notion that FZD7 is not only a marker of undifferentiated cells but also is functionally important for the maintenance of hESCs in an undifferentiated state.
Although FZD7-Fab treatment impaired expression of pluripotency-associated genes, it did not interfere with differentiation of hESCs into the mesendodermal lineage, an effect mediated by canonical WNT signaling (12) . Cells treated with exogenous Wnt3a protein down-regulate pluripotency-associated genes and enter a mesendodermal fate, as detected by the expression of SOX17 and T (BRY; Fig. 4B ). Cotreatment with FZD7-Fab did not significantly affect up-regulation of SOX17 and T expression, suggesting that FZD7 does not mediate mesendodermal differentiation. In contrast, expression of the WNT target gene SP5 was significantly reduced on treatment with FZD7-Fab. Together, these data suggest that FZD7 mediates an endogenous WNT signaling loop that maintains baseline expression of the WNT target gene SP5 and expression of the pluripotency-associated genes OCT4/POU5F1 and NANOG but does not participate in mesendodermal differentiation.
Because the primary known function of FZD proteins is to transduce WNT signals, we explored the possibility that FZD7 transduces Wnt signals to activate β-catenin-mediated transcription. As a first measure, we interrogated RNA-seq data to identify expression of WNT genes in hESCs. Consistent with other studies (14) and publically available expression data sets [e.g., the Gene Expression Atlas, www.ebi.ac.uk/gxa/ (19)], WNT3 was expressed in hESCs (Fig. S4B ). We previously purified and characterized mouse Wnt3a (20, 21) , which is 86.5% identical and 92.5% conserved compared with human WNT3, suggesting that these two Wnt proteins act in conserved biological processes. Therefore, we used purified Wnt3a to determine whether FZD7 mediates exogenous Wnt3a signaling in hESCs. To test this possibility, we used hESCs carrying a WNT/β-catenin-responsive promoter driving expression of a reporter gene encoding green fluorescent protein (GFP). This reporter, referred to as TOP (Tcf optimal promoter)-GFP, and similar WNT/β-catenin reporter elements are inactive, or poorly active, in hESCs and become activated on differentiation toward mesendodermal fates (9, 12, 13, 22) . Treatment with FZD7-Fab, which effectively binds FZD7 ( Fig. 2D and Fig. S2 ), a candidate receptor transducing the Wnt3a signal, did not activate the GFP reporter ( (Scale bar, 100 μm.) (B) FZD7 depletion by shRNA knockdown leads to a reduction of pluripotency gene expression. hESCs transduced with a shRNA directed against FZD7 exhibited a significant decline in expression of the genes FZD7, NANOG, and POU5F1/OCT4 (mean ± SD of three technical samples, normalized to EF1a and relative to mockinfected controls). **P < 0.01. , and T (BRY) was determined by qRT-PCR (mean ± SEM of four technical samples, normalized to 18S and relative to buffer control). **P < 0.01; *P < 0.05; n.s. not statistically significant. cells ( Fig. 5 A and C) . Pretreatment of hESCs with the FZD7-Fab for 24 h reduced responsiveness of the reporter cells to Wnt3a by 50% (Fig. 5A ), indicating that FZD7-Fab binding interferes with signaling of Wnt3a through FZD7. The residual activity can be attributed either to incomplete blocking by FZD7-Fab or to expression of a redundantly acting WNT receptor, such as FZD5. The reduction in signaling on FZD7-Fab pretreatment was not observed in HEK293 cells carrying a WNT/β-catenin luciferase reporter (TOP-Flash; Fig. S5 ), which lack FZD7 expression ( Fig. 2 B and C and ref. 16) . Treatment of cells with the GSK3 inhibitor CHIR98014 (CHIR), similar to Wnt3a, potently activates the TOP-GFP reporter ( Fig. 5 B and D) . However, in contrast to Wnt3a stimulation, pretreatment with FZD7-Fab has no effect on reporter activation by CHIR (Fig. 5B) . Therefore, FZD7-Fab blocks Wnt/ β-catenin signaling upstream of GSK3, most likely by interfering with receptor-ligand interactions.
In contrast to pretreatment with FZD7-Fab, simultaneous addition of Wnt3a or CHIR and FZD7-Fab to the TOP-GFP reporter cells produced the same amount of reporter activation as Wnt3a or CHIR alone (Fig. 5 C and D) , indicating that FZD7-Fab does not compete with Wnt3a for FZD7 binding. Several mechanisms are possible to explain how FZD7-Fab treatment interferes with FZD7-Wnt3a signal transduction. We found that treatment of hESCs with FZD7-Fab led to a decrease in FZD7 protein (Fig. 5E ), suggesting it is degraded or that its expression is blocked transcriptionally or translationally. The reduction in FZD7 protein levels is detectable after 4 h of treatment, with a near 50% decline of FZD7 protein levels after 12 h of treatment (Fig. 5E ). These data suggest that FZD7-Fab leads to FZD7 degradation, potentially through internalization, so that the receptor is no longer available for Wnt3a binding and signaling. FZD7 receptor internalization has also been observed in Wilms' tumor cells treated with anti-FZD7 antibody (23) .
The data presented in Figs. 3, 4A, and 5 argue for the presence of an endogenous WNT-FZD7 signaling loop required for the maintenance of hESCs in an undifferentiated state. To address this possibility, we examined the effect of blocking endogenous WNT protein with an inhibitor of WNT processing (IWP2), an inhibitor of porcupine (PORCN) (24) , an enzyme that processes WNT by attaching a lipid moiety before secretion. Treatment of hESCs with IWP2 led to decreased expression of the WNT target genes AXIN2 and SP5 (Fig. 6 A and B) , consistent with the notion that an endogenous WNT signaling pathway is active in hESCs. Furthermore, this treatment led to marked reduction in expression of the pluripotency markers OCT4/POU5F1 and NANOG (Fig. 6  C and D) . Importantly, over the course of this IWP treatment, as observed with FZD7-Fab treatment (Fig. 4A) , FZD7 expression declined (Fig. 6E) , lending additional support to the possibility that this cell surface molecule is functionally important for the maintenance of hESCs in an undifferentiated state. It should be noted that this effect of IWP2 on expression of these pluripotency markers was most striking when cells were cultured in the completely defined Essential 8 (E8) medium (25) , which is devoid of all WNT proteins or agonists. In contrast, the widely used mTeSR (Stemcell Technologies Inc.) medium contains lithium (1 mM LiCl) (26) , which inhibits GSK3 activity and thereby leads to WNT signal activation. Likewise, mouse embryonic fibroblasts (MEFs) and MEF-conditioned medium, which are commonly used for growth of hESCs, could potentially provide WNT proteins and agonists, thereby obfuscating effects of inhibition of WNT protein secretion from hESCs. Therefore, the endogenous FZD7/WNT signaling loop, which we postulate is required to maintain hESCs in an undifferentiated state, is only inhibited by IWP2 when all sources of exogenous WNT activity are eliminated. , and FZD7 (E) was determined by qRT-PCR at the indicated passage number (mean ± SEM of four technical samples, normalized to 18S and relative to buffer control). **P < 0.01; ***P < 0.001.
Discussion
It is well established that WNT/β-catenin signaling maintains stem cell populations in an undifferentiated state. However, the role of this pathway in human pluripotent stem cell biology remains contentious. Using several lines of evidence, we demonstrated that an endogenous WNT-FZD7 signaling pathway is required to maintain hESCs in an undifferentiated state. First, we showed that the WNT receptor FZD7 is highly expressed in undifferentiated hESCs, hinting that this receptor may be transducing a WNT signal. Second, using two independent methods to disrupt FZD7 function (shRNA-mediated knockdown and a FZD7-specific Fab), we showed that this WNT receptor is critical to maintain hESCs in an undifferentiated state. This finding is further supported by our observation that treatment of cells with a PORCN inhibitor, which disrupts endogenous WNT processing and secretion, also reduces the pluripotency of hESCs. The identity of the endogenous WNT ligand signaling through FZD7 remains unknown. Genome-wide expression profiling (RNA-seq) identified WNT3 as the most abundantly transcribed WNT gene in hESCs, consistent with publicly available expression data sets [e.g., the Gene Expression Atlas (19) ]. In addition, several members of the RSPO gene family, which encode secreted molecules that augment WNT signaling activity (27) (28) (29) , are expressed in hESCs. WNT3 expression was found to be variable among various hESC lines, with highest relative levels of expression correlating with a propensity to differentiate into endodermal derivatives (14) . Together with our finding that FZD7-Fab specifically blocks signaling by Wnt3a, it is likely that WNT3, which is highly conserved to Wnt3a, constitutes a selfrenewal ligand interacting with FZD7 in hESCs. A functional connection between FZD7 and WNT3 has also been suggested to exist in hepatic cells (30) . However, other WNT ligands may act redundantly with WNT3 and functionally interact with FZD7 to contribute to hESC self-renewal. A definitive identification of the critical WNT ligand will require quantitative affinity measurements between WNTs and their FZD receptors.
Other studies have indicated that hESCs have low levels of endogenous WNT signaling and that active WNT signaling enhances endodermal differentiation propensity (14, 22) . Using a WNT-responsive reporter element to monitor endogenous WNT signaling activity, Blauwkamp and colleagues observed the presence of both WNT high and WNT low hESC populations, with the WNT high population leaning toward an endodermal fate (22) . We did not observe WNT reporter activity in hESCs carrying a WNT-responsive GFP reporter, a difference that likely stems from the high degree of heterogeneity among distinct hESC lines. In support of this explanation, a recent study found that levels of WNT3 expression correlate with the propensity of hESCs to differentiate into definitive endoderm (14) . Therefore, we propose, as suggested by studies in the hematopoietic system (31) , that low WNT signaling activity is required for the maintenance of an undifferentiated state, whereas elevated WNT signaling activity shuttles cells toward mesendodermal fates, consistent with WNT's role in the initiation of gastrulation (32) . Furthermore, our data showing that FZD7-Fab blocks endogenous and exogenous WNT signaling while having no effect on mesendodermal differentiation suggest that FZD7 function is dedicated to the maintenance of the pluripotent state and does not mediate the effect of high Wnt signaling activity on mesendodermal differentiation. We speculate that other WNT receptors, such as FZD3 and/or FZD5, which are expressed in undifferentiated hESCs, mediate WNT-induced mesendodermal differentiation. Additional studies are needed to address this possibility.
Exogenous WNT stimulation induces differentiation of hESCs into mesendodermal lineages (12, 13) , and treatment of undifferentiated hESCs with a canonical WNT protein or a GSK3 inhibitor has become an established method for inducing definitive endoderm (18, (33) (34) (35) . These observations, combined with our current findings, suggest that WNT acts as a morphogen, with low levels of signaling promoting hESC self-renewal and high levels inducing endodermal differentiation. Such morphogen activities are well-established in other systems, especially in flies, where Wingless (a Drosophila melanogaster Wnt homolog) has distinct activities at high local concentrations versus low distant concentrations (reviewed in ref. 36 ). Exploiting these morphogen activities of WNT proteins, as well as other developmental signaling molecules such as FGF, sonic hedgehog (SHH), and TGF-β, will likely be critical in differentiating specific cell types from hESCs. In a recent study, this WNT morphogen activity has been used to assign a specific rostro-caudal positional identity to neural progenitor cells derived from hESCs (37) .
Our findings demonstrate that FZD7 marks undifferentiated hESCs and that its expression is functionally important for the maintenance of the pluripotent state. This discovery adds to the expanding repertoire of cell surface molecules required for hESC self-renewal, including FGF, insulin-like growth factor (IGF), and epidermal growth factor (EGF) receptors (38) (39) (40) , E-cadherin (41) (42) (43) (44) , and L1 cell adhesion molecule (45) . Therefore, the cellular machinery regulating hESC pluripotency is not restricted to nuclear factors such as OCT4, NANOG, and SOX2 but is directly influenced by signals originating from the cell surface. Reagents, such as FZD7-Fab described here, may provide powerful tools to isolate and enrich cells with pluripotent properties.
In addition to the observation that FZD7 expression is increased in undifferentiated human pluripotent stem cells, FZD7 expression has been associated with several types of cancer, hinting at a possible function in cancer stem cells (23, (46) (47) (48) (49) (50) . These studies have led to significant interest in FZD7 as a cancer stem cell marker, the targeting of which may be of therapeutic value in the treatment of cancers in which WNT signaling is deregulated (51) . The specific FZD7 binding protein (FZD7-Fab), which blocks FZD7 function, as well as Wnt3a signaling, may represent an effective method to disrupt WNT-FZD7 signaling in cancer cells.
Materials and Methods
Cell Lines and Culture Conditions. All media components are from Life Technologies unless indicated otherwise. Mouse embryonic fibroblast (MEF), HEK293, and HEK293T cells were cultured in 1× high glucose DMEM, 10% (vol/vol) FBS, and 1% (vol/vol) L-glutamine penicillin/streptomycin. hESCs HUES9, HUES6, and HUES16 and human induced pluripotent stem cell lines (52) were cultured in 1× DMEM-F12, 20% (vol/vol) Knockout Serum Replacement, 1% (vol/vol) nonessential amino acids, 0.5% (vol/vol) glutamine, 120 μM 2-mercaptoethanol (Sigma). H1/WA01 cells were cultured in E8 medium (25) . hESC lines were maintained on feeder layers of mitotically inactivated MEFs (2 × 10 4 /cm 2 ; Millipore) or on Matrigel (BD Biosciences)
with MEF conditioned media. MEF conditioned media was produced by culturing hESC medium on MEFs for 24 h, followed by sterile filtering. Plasmids for FZD7 knockdown and overexpression are provided in SI Materials and Methods.
RNA and Protein Analysis. High-Throughput RNA Sequencing. Total RNA from H1 (WA01; National Institutes of Health Stem Cell Registration Number 0043) was depleted of genomic DNA and rRNA. After ligating the Adaptor Mix, fragmented RNA was converted to the first strand cDNA by ArrayScript Reverse Transcriptase (Ambion), size selected (100-200 bp) by gel electrophoresis, and amplified by PCR, using adaptor-specific primers. Deep sequencing was performed on an Illumina HiSeq2000. Differential gene expression analysis of RNA-seq experiments was performed with TopHat and Cufflinks, as previously described (53, 54) . Briefly, raw reads were quality filtered, mapped, and aligned to the reference human genome (hg19) with TopHat. Finally, Cuffdiff was used to calculate gene expression levels as reads per thousand transcript bases per million reads mapped (RPKM). Statistically significant differences in gene expression were calculated from RPKM values. . Genomic integrity of hESCs and genetically modified lines was confirmed by cytogenetic analysis on 20 metaphase cells, using standard protocols for G-banding (Cells Line Genetics).
Supporting Information
For IWP treatment (Fig. 6 ), HUES9 cells were maintained in E8 medium (1) on BD Matrigel-coated (BD Biosciences) tissue culture dishes. Culture medium was supplemented daily with either DMSO or inhibitor of WNT processing 2 (IWP2) (2) solution to a final concentration of 0.1% (vol/vol). IWP-2 solutions of 50 and 500 μM were prepared fresh from a frozen stock at the beginning of each passage. When cells reached 85% confluence, cells were dissociated with Accutase and seeded onto fresh Matrigelcoated plates at a density of 11,000 cells/cm 2 with the Rock inhibitor Y-27632 (10 μM) and either DMSO or IWP-2 at the same concentration in which they were previously cultured.
RNA Analysis. Total RNA was extracted using NucleoSpin RNA II kit (Machery-Nagel) according to manufacturer's instructions. A microgram of RNA was reverse-transcribed, using qScript cDNA Supermix (Quanta Biosciences), and subsequently, 1 μL of template was used per PCR. SensiFAST SYBR Hi-Rox real-time PCR reactions (Bioline) were performed in triplicate, using a CFX96 PCR machine (Bio-Rad) and 40 cycles of amplification (95°C, 5 s; 60°C, 15 s). PCR primers (Table S1 ) were designed using Primer3 software. The specificity of the primers was obtained with a denaturation curve analysis (55-98°C), resulting in a single peak. Gene expression was normalized to either EF1a or RNA18S5 levels, as indicated. Ct values were obtained with Bio-Rad CFX Manager software, and Delta Ct values were calculated, with a final analysis done in MS Excel (Microsoft).
Protein Analysis. HEK293 cells were transiently transfected with expression vectors carrying FZD cDNAs, using a polyethylenimine (PEI)-mediated transfection method. For immunoblot analysis, cells (HEK293 and hESCs) were washed with PBS and lysed on ice with 1% Triton X-100, 150 mM NaCl, and 50 mM Tris·Cl at pH 7.5. Twenty micrograms of total protein lysate (as determined by Bradford assay) were resolved by SDS/PAGE, transferred to Nitrocellulose (Bio-Rad), probed with FZD7-fragment antigen binding (Fab) (Alere), and detected with HRP-conjugated antimouse IgG-HRP (Santa Cruz Biotechnology), using chemiluminescence reagents (Perkin-Elmer Western Lightning ECL) and autoradiography.
For flow cytometry of FZD7, hESCs (HUES 9 and HUES 16) cells were grown to confluency, dissociated with Accutase (Life Technologies), and passed through a cell strainer to remove cell aggregates. For analysis of overexpressed FZD7 in HEK293 by flow cytometry, cells were dissociated with Trypsin-0.25% EDTA (Life Technologies). Unfixed cells were stained with FZD7-Fab (Allere), followed by a R-phycoerythrin-cyanine dye 7 (PE-Cy7)-conjugated rat anti-mouse Ig, kappa light chain (BD Biosciences). Flow cytometry was performed on a FACS Canto II (BD Biosciences). Data were acquired using BD FACSDiva and analyzed using FlowJo software (Tree Star).
For isolation of cell populations with high and low levels of FZD7 cell surface expression by fluorescence-based cell sorting, Accutase-dissociated HUES9 cells were labeled as described earlier and sorted using a FACS Aria 2 (BD Biosciences). Total RNA from sorted cells was subsequently analyzed as described earlier.
Blocking Wnt3a Signaling With FZD7-Fab. For the pretreatment experiments ( Fig. 5 A and B; Fig. S5A ), FZD7-Fab was added to HUES9-TOP-GFP or HEK293-TOP-Flash cells for 24 h. At that point, cells were treated with either Wnt3a (generated as described in ref. 
